-+ 0.00%
-+ 0.00%
-+ 0.00%

NEUROGENE ANNOUNCES RECENT ACHIEVEMENTS AND ANTICIPATED 2026 KEY MILESTONES FOR NGN-401, A POTENTIAL BEST-IN-CLASS GENE THERAPY FOR RETT SYNDROME

Reuters·01/12/2026 12:00:02

Please log in to view news